Skip to main content

Chronic Rejection in Reconstructive Transplantation

  • Chapter
  • First Online:

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

Clinical experience in vascularized composite allotransplantation (VCA) is accumulating, with about 25 % of the clinical cases now five or more years posttransplantation. To date, few centers have reported sequelae related to chronic rejection, and in fact, some centers have reported a clear lack of chronic rejection. Unfortunately, our center has had experience with graft vasculopathy in hand transplant recipients, and other characteristics of chronic rejection such as thinning of the skin and loss of adnexal structures have presented in one of our patients. In this chapter, we briefly review chronic rejection in solid organ transplantation and apply lessons learned to what is being presented by VCA recipients. The early experience suggests that VCA patients may be somewhat protected from chronic rejection, but that it can occur, and unlike solid organ transplants there may be multiple primary tissue targets. Like solid organ transplantation, the development of tolerance-inducing protocols with control of both acute and chronic rejection with reduced or no systemic immunosuppression is needed. It remains to be seen whether conventional immunosuppression will be any more effective in treating chronic rejection in VCA patients than it has been for solid organ recipients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009;15(21):2561–9.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Azuma H, Tullius SG, Heemann UW, Tilney NL. Nonimmune factors may contribute to chronic rejection of kidney transplants. Transplant Proc. 1994;26(4):2109–10. (Available from: PM:8066686)

    CAS  PubMed  Google Scholar 

  3. Brandacher G, Lee WP, Schneeberger S. Minimizing immunosuppression in hand transplantation. Expert Rev Clin Immunol. 2012;8(7):673–83.

    Article  CAS  PubMed  Google Scholar 

  4. Brenner MJ, Tung TH, Jensen JN, Mackinnon SE. The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Joint Surg Am. 2002;84-A(10):1861–70. (Available from: PM:12377920)

    PubMed  Google Scholar 

  5. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007;117(11):3498–506.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, Landin L, Remmelink M, Hewitt CW, Landgren T, Lyons B, Drachenberg CB, Solez K, Kirk AD, Kleiner DE, Racusen L. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8(7):1396–400.

    Article  CAS  PubMed  Google Scholar 

  7. Christensen J, Ibrahim Z, Wu L, Leto Barone A, Furtmuller M, Sarhane K, Al-Rakan M, Schneeberger S, Shores JT, Bonawitz S, Cooney D, Sacks J, Lee WP, Brandacher G. Mechanical trauman can reactivate an alloimmune response against the skin component in a large animal vascularized composite allotransplantation (VCA) model of operational tolerance. Am Transpl Congr 2013;13[S5]:203.

    Google Scholar 

  8. Clatworthy MR. B Cell responses to allograft—more common than we thought? Am J Transplant. 2013;13(7):1629–30.

    Article  CAS  PubMed  Google Scholar 

  9. Clatworthy MR, Espeli M, Torpey N, Smith KG. The generation and maintenance of serum alloantibody. Curr Opin Immunol. 2010;22(5):669–81. (Available from: PM:20932734)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, Daskal I, El-Monayeri MS, Fontes P, Fung J, Gridelli B, Guido M, Haga H, Hart J, Honsova E, Hubscher S, Itoh T, Jhala N, Jungmann P, Khettry U, Lassman C, Ligato S, Lunz JG, III, Marcos A, Minervini MI, Molne J, Nalesnik M, Nasser I, Neil D, Ochoa E, Pappo O, Randhawa P, Reinholt FP, Ruiz P, Sebagh M, Spada M, Sonzogni A, Tsamandas AC, Wernerson A, Wu T, Yilmaz F. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44(2):489–501.

    Article  PubMed  Google Scholar 

  11. Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int. 2011;24(1):e1–5. (Available from: PM:20958796)

    Article  PubMed  Google Scholar 

  12. Edelman ER, Danenberg HD. Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation 2003;108(1):6–8. (Available from: PM:12847052)

    Article  PubMed  Google Scholar 

  13. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324(10):667–74. (Available from: PM:1994250)

    Article  CAS  PubMed  Google Scholar 

  14. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373(9674):1550–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86(21):8412–8416. (Available from: PM:2813399)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Giovanelli M, Gupte GL, Sharif K, Mayer DA, Mirza DF. Chronic rejection after combined liver and small bowel transplantation in a child with chronic intestinal pseudo-obstruction: a case report. Transpl Proc. 2008;40(5):1763–67.

    Article  CAS  Google Scholar 

  17. Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM III, Tilney NL. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation. 1993;56(3):643–50.

    Article  CAS  PubMed  Google Scholar 

  18. Heemann U, Lutz J. Pathophysiology and treatment options of chronic renal allograft damage. Nephrol Dial Transpl. 2013;28(10):2438–46.

    Article  CAS  Google Scholar 

  19. Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant. 2009;9(11):2532–41.

    Article  CAS  PubMed  Google Scholar 

  20. Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg JR, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter JP, Tamm M. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(6):973–80.

    Article  PubMed  Google Scholar 

  21. Hornick P, Rose M. Chronic rejection in the heart. Methods Mol Biol. 2006;333:131–44.

    PubMed  Google Scholar 

  22. Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation–is it reversible? Transplantation. 1991;51(5):1004–10.

    Article  CAS  PubMed  Google Scholar 

  23. Jensen JN, Mackinnon SE. Composite tissue allotransplantation: a comprehensive review of the literature–Part II. J Reconstr Microsurg. 2000;16(2):141–57.

    CAS  PubMed  Google Scholar 

  24. Joosten SA, van KC, Paul LC. Pathogenesis of chronic allograft rejection. Transpl Int. 2003;16(3):137–45.

    Article  CAS  PubMed  Google Scholar 

  25. Kanitakis J, McGregor B, Badet L, Petruzzo P, Morelon E, Devauchelle B, Dubernard JM. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007;84(2):265–7. (Available from: PM:17667820)

    Article  CAS  PubMed  Google Scholar 

  26. Kaufman CL, Marvin MR, Ouseph R, Manon-Matos Y, Blair B, Kutz JE. Evidence for chronic rejection of the skin and adnexal structures in a hand transplant recipient at six years post transplant without significant graft vasculopathy. Am J Transplant. 2013;13[S5]:286.

    Google Scholar 

  27. Kaufman CL, Ouseph R, Blair BW, Kutz JE, Tsai TM, Scheker LR, Tien HY, Moreno R, Ozyrekoglu T, Banegas R, Murphy EE, Burns C, Zavan B, Cook DF, Marvin MR. Graft vasculopathy in clinical hand transplantation. Am J Transplant. 2012;12(4):1004–16.

    Article  CAS  PubMed  Google Scholar 

  28. Khan MS, Heinle JS. Pediatric thoracic multiorgan transplantation. Tex Heart Inst J. 2012;39(6):850–1.

    PubMed Central  PubMed  Google Scholar 

  29. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966;2(7465):662–5.

    Article  CAS  PubMed  Google Scholar 

  30. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–62.

    Article  CAS  PubMed  Google Scholar 

  31. Landin L, Cavadas PC, Ibanez J, Roger I, Vera-Sempere F. CD3 + -mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009;87(5):776–81. (Available from: PM:19295326)

    Article  CAS  PubMed  Google Scholar 

  32. Lanzetta M, Petruzzo P, Margreiter R, Dubernard JM, Schuind F, Breidenbach W, Lucchina S, Schneeberger S, van HC, Granger D, Pei G, Zhao J, Zhang X. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005;79(9):1210–4. (Available from: PM:15880072)

    Article  PubMed  Google Scholar 

  33. Lineaweaver WC. Chronic rejection, hand transplantation, and the monkey’s paw. Microsurgery. 2006;26(6):419–20.

    Article  PubMed  Google Scholar 

  34. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant. 2011;11(6):1226–35.

    Article  CAS  PubMed  Google Scholar 

  35. Lynch RJ, Silva I, Chen BJ, Punch JD, Cascalho M, Platt JL. Cryptic B cell response to renal transplantation. Am J Transplant. 2013;13(7):1713–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol. 2009;4:19–47. (Available from: PM:18717641)

    Article  CAS  PubMed  Google Scholar 

  37. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100(7):967–78. (Available from: PM:17431198)

    Article  CAS  PubMed  Google Scholar 

  38. Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93(9):855–9.

    Article  CAS  PubMed  Google Scholar 

  39. Mundinger GS, Munivenkatappa R, Drachenberg CB, Ha JS, Vaca EE, Shipley ST, Papadimitriou JC, Bartlett ST, Rodriguez ED, Barth RN. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation 2013;95(10):1204–10.

    Article  CAS  PubMed  Google Scholar 

  40. Murphy BD, Zuker RM, Borschel GH. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. J Plast Reconstr Aesthet Surg. 2013;(13):10.

    Google Scholar 

  41. Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011;378(9800):1428–37.

    Article  PubMed  Google Scholar 

  42. Orloff SL, Hwee YK, Kreklywich C, Andoh TF, Hart E, Smith PA, Messaoudi I, Streblow DN. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naive recipients. Am J Transplant. 2011;11(1):45–55. (Available from: PM:21199347)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R, Schneeberger S, Breidenbach W, Kaufman C, Jablecki J, Schuind F, Dumontier C. The international registry on hand and composite tissue transplantation. Transplantation. 2010;90(12):1590–4. (Available from: PM:21052038)

    Article  PubMed  Google Scholar 

  44. Petruzzo P, Kanitakis J, Badet L, Pialat JB, Boutroy S, Charpulat R, Mouly J, Gazarian A, Lanzetta M, Brunet M, Devauchelle B, Testelin S, Martin X, Dubernard JM, Morelon E. Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients. Am J Transplant. 2011;11(4):808–16. (Available from: PM:21446980)

    Article  CAS  PubMed  Google Scholar 

  45. Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR Jr., Smith K, Bourge RC, Tallaj JA, Rayburn BK, Benza R, Zorn G, Leon K, Wille K, Deierhoi M, George JF. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transpl. 2005;24(11):1828–33.

    Article  Google Scholar 

  46. Rana A, Robles S, Russo MJ, Halazun KJ, Woodland DC, Witkowski P, Ratner LE, Hardy MA. The combined organ effect: protection against rejection? Ann Surg. 2008;248(5):871–9.

    Article  PubMed  Google Scholar 

  47. Reichman TW, Marino SR, Milner J, Harland RC, Cochrane A, Millis JM, Testa G. Acute humoral rejection in an ABO compatible combined liver-kidney transplant–the kidney is not always protected. Am J Transplant. 2009;9(8):1957–60.

    Article  CAS  PubMed  Google Scholar 

  48. Reischig T. Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies. Expert Rev Anti Infect Ther. 2010;8(8):903–10.

    Article  PubMed  Google Scholar 

  49. Sirois MG, Simons M, Kuter DJ, Rosenberg RD, Edelman ER. Rat arterial wall retains myointimal hyperplastic potential long after arterial injury. Circulation 1997;96(4):1291–8. (Available from: PM:9286961)

    Article  CAS  PubMed  Google Scholar 

  50. Sivakumar B, Haloob N, Puri A, Latif A, Ghani S, Brough V, Molloy J, Clarke A, Denton CP, Butler PE. Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantation. J Plast Reconstr Aesthet Surg. 2010;63(10):1669–76.

    Article  CAS  PubMed  Google Scholar 

  51. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753–60.

    Article  CAS  PubMed  Google Scholar 

  52. Starzl TE, Marchioro TL, Rifkind D, Rowlands DT Jr, Waddell WR. Clinical experience with organ transplantation. South Med J. 1965;58:131–47.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol. 2004;286(6):L1129–39.

    Article  CAS  PubMed  Google Scholar 

  54. Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long term kidney homograft surviviors. First Histocompatibility Workshop, 83. 1964.

    Google Scholar 

  55. Tilney NL. Renal transplantation between identical twins: a review. World J Surg. 1986;10(3):381–8.

    Article  CAS  PubMed  Google Scholar 

  56. Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest. 2011;140(2):502–8.

    Article  PubMed  Google Scholar 

  57. Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45(9):1538–42. (Available from: PM:15862431)

    Article  PubMed  Google Scholar 

  58. Unadkat JV, Schneeberger S, Horibe EH, Goldbach C, Solari MG, Washington KM, Gorantla VS, Cooper GM, Thomson AW, Lee WP. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant. 2010;10(2):251–61. (Available from: PM:20041866)

    Article  CAS  PubMed  Google Scholar 

  59. Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Saggar R, Lynch JP, Belperio JA. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med. 2010;31(2):189–207.

    Article  PubMed  Google Scholar 

  60. Weiss MJ, Madsen JC, Rosengard BR, Allan JS. Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci. 2008;13:2980–8. (Available from: PM:17981771)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation. 2010;90(2):113–20.

    Article  PubMed  Google Scholar 

  62. Yamani MH, Yousufuddin M, Starling RC, Tuzcu M, Ratliff NB, Cook DJ, Abdo A, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant. 2004;23(3):272–6.

    Article  PubMed  Google Scholar 

  63. Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol. 2006;16(3–4):148–57.

    Article  CAS  PubMed  Google Scholar 

  64. Zeevi A, Morel P, Spichty K, Dauber J, Yousem S, Williams P, Grgurich W, Pham S, Iacono A, Keenan R, Duquesnoy R, Griffith B. Clinical significance of CMV-specific T helper responses in lung transplant recipients. Hum Immunol. 1998;59(12):768–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the Department of Defense, Office of Army Research, and the Office of Naval Research as well as the Jewish Hospital Foundation, the Kleinert Kutz Hand Care Center, and the Christine M. Kleinert Institute for Hand and Microsurgery for support of these studies.

Disclosure: The authors do not have any conflicts to disclose regarding this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina L. Kaufman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kaufman, C. et al. (2015). Chronic Rejection in Reconstructive Transplantation. In: Brandacher, G. (eds) The Science of Reconstructive Transplantation. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2071-6_13

Download citation

Publish with us

Policies and ethics